Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK anal cancer chemoradiation and maintenance therapy trial
ISRCTN26715889Phase 2Completed
- Sponsor
- Cancer Research UK
- Start
- Feb 2001
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of fluorouracil, mitomycin c and cisplatin in anal cancer (4 arms), sponsored by Cancer Research UK. Primary endpoints: Complete response rate at six months, Grade 4 toxicity and 1 more. Started Feb 2001; status: completed.
02
Drugs
fluorouracilmitomycin ccisplatin
03
Conditions
anal cancer
Beyond the preview
Go deeper on ISRCTN26715889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26715889.